# To Compare the Efficacy and Tolerability of A. Paniculata/A. Chilensis in Individuals With URTI

> **NCT04955327** · PHASE3 · COMPLETED · sponsor: **Vedic Lifesciences Pvt. Ltd.** · enrollment: 225 (actual)

## Conditions studied

- Upper Respiratory Tract Infection

## Interventions

- **DRUG:** A. Paniculata
- **DRUG:** A. Chilensis
- **DRUG:** A. Paniculata and A. Chilensis
- **DRUG:** Microcrystalline cellulose

## Key facts

- **NCT ID:** NCT04955327
- **Lead sponsor:** Vedic Lifesciences Pvt. Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-20
- **Primary completion:** 2022-02-25
- **Final completion:** 2022-02-25
- **Target enrollment:** 225 (ACTUAL)
- **Last updated:** 2022-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04955327

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04955327, "To Compare the Efficacy and Tolerability of A. Paniculata/A. Chilensis in Individuals With URTI". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04955327. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*